Press release
Postoperative Pain Pipeline Drugs Analysis Report, 2024: FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration by DelveInsight | Allay Therapeutics, SiteOne Therapeutics, LipoCure, Flexion Therapeutics, Nevakar, Inc., Jia
"Postoperative Pain Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Postoperative Pain Market.
The Postoperative Pain Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Some of the key takeaways from the Postoperative Pain Pipeline Report: https://www.delveinsight.com/sample-request/postoperative-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Postoperative Pain treatment therapies with a considerable amount of success over the years.
• Postoperative Pain companies working in the treatment market are InSitu Biologics, Bexson Biomedical, Allay Therapeutics, SiteOne Therapeutics, LipoCure, Flexion Therapeutics, Nevakar, Inc., Jiangsu HengRui Medicine Co., Ltd., Concentric Analgesics, Oculis Pharma, Haisco Pharmaceutical Group, Vivozon Pharmaceutical Inc, and others, are developing therapies for the Postoperative Pain treatment
• Emerging Postoperative Pain therapies in the different phases of clinical trials are- INSB-200, BB-106, ATX-201, ST-2427, LC-400, FX 301, NVK-009, HR021618, CA-008, OCS-01, HSK21542, VVZ-149, and others are expected to have a significant impact on the Postoperative Pain market in the coming years.
• In May 2024, SPR Therapeutics has announced positive results from a trial examining its peripheral nerve stimulation (PNS) device for knee replacement patients suffering from chronic knee pain. The prospective trial evaluated the SPRINT PNS system, developed by US-based SPR Therapeutics, over a 60-day therapy period in patients experiencing postoperative pain following total knee arthroplasty, commonly known as total knee replacement surgery.
• In August 2023, Arthritis Innovation Corporation (AIC), MedinCell's collaborator, has completed patient enrollment for the initial of two Phase III trials involving F14 (also known as mdc-CWM), designed to alleviate localized pain following total knee replacement (TKR) surgery. This randomized, multicenter, double-blind study aims to evaluate the safety and effectiveness of a solitary dose of F14 for managing post-operative pain in patients undergoing unilateral TKR.
Postoperative Pain Overview
Postoperative pain refers to discomfort or soreness experienced by patients after surgery. It can vary in intensity and duration depending on the type of surgery and individual pain thresholds. Effective management is crucial for recovery, often involving medications, nerve blocks, or other techniques to alleviate discomfort and promote healing.
Get a Free Sample PDF Report to know more about Postoperative Pain Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/postoperative-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Emerging Postoperative Pain Drugs Under Different Phases of Clinical Development Include:
• INSB-200: InSitu Biologics
• BB-106: Bexson Biomedical
• ATX-201: Allay Therapeutics
• ST-2427: SiteOne Therapeutics
• LC-400: LipoCure
• FX 301: Flexion Therapeutics
• NVK-009: Nevakar, Inc.
• HR021618: Jiangsu HengRui Medicine Co., Ltd.
• CA-008: Concentric Analgesics
• OCS-01: Oculis Pharma
• HSK21542: Haisco Pharmaceutical Group
• VVZ-149: Vivozon Pharmaceutical Inc
Postoperative Pain Route of Administration
Postoperative Pain pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Topical
Postoperative Pain Molecule Type
Postoperative Pain Products have been categorized under various Molecule types, such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
Postoperative Pain Pipeline Therapeutics Assessment
• Postoperative Pain Assessment by Product Type
• Postoperative Pain By Stage and Product Type
• Postoperative Pain Assessment by Route of Administration
• Postoperative Pain By Stage and Route of Administration
• Postoperative Pain Assessment by Molecule Type
• Postoperative Pain by Stage and Molecule Type
DelveInsight's Postoperative Pain Report covers around 50+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration
Further Postoperative Pain product details are provided in the report. Download the Postoperative Pain pipeline report to learn more about the emerging Postoperative Pain therapies
https://www.delveinsight.com/sample-request/postoperative-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key companies in the Postoperative Pain Therapeutics Market include:
Key companies developing therapies for Postoperative Pain are - Pfizer Inc., AbbVie, GlaxoSmithKline plc, Heron Therapeutics, and AFT Pharmaceuticals, and others.
Postoperative Pain Pipeline Analysis:
The Postoperative Pain pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Postoperative Pain with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Postoperative Pain Treatment.
• Postoperative Pain key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Postoperative Pain Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Postoperative Pain market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Download Sample PDF Report to know more about Postoperative Pain drugs and therapies
https://www.delveinsight.com/sample-request/postoperative-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Postoperative Pain Pipeline Market Drivers
• Rise in the number of surgical procedures worldwide, government's initiative to promote better postoperative pain treatment are some of the important factors that are fueling the Postoperative Pain Market.
Postoperative Pain Pipeline Market Barriers
• However, adverse effects associated with the medications, research Gaps in Practice Guidelines for Acute Postoperative Pain Management and other factors are creating obstacles in the Postoperative Pain Market growth.
Scope of Postoperative Pain Pipeline Drug Insight
• Coverage: Global
• Key Postoperative Pain Companies: InSitu Biologics, Bexson Biomedical, Allay Therapeutics, SiteOne Therapeutics, LipoCure, Flexion Therapeutics, Nevakar, Inc., Jiangsu HengRui Medicine Co., Ltd., Concentric Analgesics, Oculis Pharma, Haisco Pharmaceutical Group, Vivozon Pharmaceutical Inc, and others
• Key Postoperative Pain Therapies: INSB-200, BB-106, ATX-201, ST-2427, LC-400, FX 301, NVK-009, HR021618, CA-008, OCS-01, HSK21542, VVZ-149, and others
• Postoperative Pain Therapeutic Assessment: Postoperative Pain current marketed and Postoperative Pain emerging therapies
• Postoperative Pain Market Dynamics: Postoperative Pain market drivers and Postoperative Pain market barriers
Request for Sample PDF Report for Postoperative Pain Pipeline Assessment and clinical trials
https://www.delveinsight.com/sample-request/postoperative-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1. Postoperative Pain Report Introduction
2. Postoperative Pain Executive Summary
3. Postoperative Pain Overview
4. Postoperative Pain- Analytical Perspective In-depth Commercial Assessment
5. Postoperative Pain Pipeline Therapeutics
6. Postoperative Pain Late Stage Products (Phase II/III)
7. Postoperative Pain Mid Stage Products (Phase II)
8. Postoperative Pain Early Stage Products (Phase I)
9. Postoperative Pain Preclinical Stage Products
10. Postoperative Pain Therapeutics Assessment
11. Postoperative Pain Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Postoperative Pain Key Companies
14. Postoperative Pain Key Products
15. Postoperative Pain Unmet Needs
16 . Postoperative Pain Market Drivers and Barriers
17. Postoperative Pain Future Perspectives and Conclusion
18. Postoperative Pain Analyst Views
19. Appendix
20. About DelveInsight
Related Reports:
Postoperative Pain Epidemiology https://www.delveinsight.com/report-store/postoperative-pain-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Postoperative Pain Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports:
Duchenne Muscular Dystrophy Market
https://www.delveinsight.com/report-store/duchenne-muscular-dystrophy-market
DelveInsight's "Duchenne Muscular Dystrophy Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of Duchenne Muscular Dystrophy historical and forecasted epidemiology as well as the Duchenne Muscular Dystrophy market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.
Generalized Myasthenia Gravis Market
https://www.delveinsight.com/report-store/generalized-myasthenia-gravis-gmg-market
DelveInsight's 'Generalized Myasthenia Gravis Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the Generalized Myasthenia Gravis, historical and forecasted epidemiology as well as the market trends in the United States, EU-5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Glioblastoma Market
https://www.delveinsight.com/report-store/glioblastoma-market
DelveInsight's "Glioblastoma Market Insights, Epidemiology and Market Forecast- 2032" report delivers an in-depth understanding of the Glioblastoma, historical and forecasted epidemiology as well as the Glioblastoma market trends in the United States, the EU-4 (Germany, Spain, Italy, and France), the United Kingdom, and Japan.
Sickle Cell Disease Market
https://www.delveinsight.com/report-store/sickle-cell-disease-6mm-market
DelveInsight's "Sickle Cell Disease Market Insights, Epidemiology and Market Forecast- 2032" report delivers an in-depth understanding of the Sickle Cell Disease, historical and forecasted epidemiology as well as the Sickle Cell Disease market trends in the United States, the EU-4 (Germany, Spain, Italy, and France), the United Kingdom, and Japan. Among the 6MM countries the Sickle cell disease market size was valued ~USD 650 million in 2023 and is expected to increase throughout the forecast period (2024-2034).
Holter Monitor Market
https://www.delveinsight.com/report-store/holter-monitor-market
The Global Holter Monitor market will grow at a CAGR of 6.13% during the forecast period from 2024 to 2030. The stellar growth observed in the market is primarily due to the growing burden of various cardiovascular disorders which leads to abnormal heart rhythm such as atrial fibrillation, and heart palpitations, among others that may require monitoring through Holter monitors.
Contact Us:
Gaurav Bora
gbora@delveinsight.com
+14699457679
Healthcare Consulting
https://www.delveinsight.com/consulting-services
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Postoperative Pain Pipeline Drugs Analysis Report, 2024: FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration by DelveInsight | Allay Therapeutics, SiteOne Therapeutics, LipoCure, Flexion Therapeutics, Nevakar, Inc., Jia here
News-ID: 3562597 • Views: …
More Releases from DelveInsight Business Research
Ataxia Telangiectasia Market Dynamics Indicate Upward Trajectory Through 2034, R …
DelveInsight's "Ataxia Telangiectasia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Ataxia Telangiectasia, historical and forecasted epidemiology as well as the Ataxia Telangiectasia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Ataxia Telangiectasia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Ataxia Telangiectasia Market Forecast
https://www.delveinsight.com/sample-request/ataxia-telangiectasia-at-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Primary Biliary Cholangitis Market Expected to Gain Momentum Through 2034, Accor …
DelveInsight's "Primary Biliary Cholangitis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Primary Biliary Cholangitis, historical and forecasted epidemiology as well as the Primary Biliary Cholangitis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Primary Biliary Cholangitis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Primary Biliary Cholangitis…
Hypertrophic Cardiomyopathy Market to Show Remarkable Growth Trends from 2024 to …
DelveInsight's "Hypertrophic Cardiomyopathy Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Hypertrophic Cardiomyopathy, historical and forecasted epidemiology as well as the Hypertrophic Cardiomyopathy market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Hypertrophic Cardiomyopathy market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Hypertrophic Cardiomyopathy Market Forecast
https://www.delveinsight.com/sample-request/hypertrophic-cardiomyopathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Kidney Transplant Rejection Market Expected to Experience Major Growth by 2034, …
DelveInsight's "Kidney Transplant Rejection Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Kidney Transplant Rejection, historical and forecasted epidemiology as well as the Kidney Transplant Rejection market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Kidney Transplant Rejection market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Kidney Transplant Rejection…
More Releases for Postoperative
Postoperative Acute Pain Market Trends, Treatments, and Global Forecast
Postoperative acute pain (POAP) remains one of the most significant challenges in clinical care, affecting nearly 80% of patients after surgery. Poorly managed pain can lead to complications such as delayed recovery, prolonged hospital stays, readmissions, and higher healthcare costs. Traditionally, opioid analgesics have been the cornerstone of treatment, but rising concerns around opioid dependency and adverse effects are fueling demand for safer, multimodal pain management approaches.
Download Full PDF Sample…
Postoperative Pain Therapeutics Market Innovations and Trends for 2032
The Postoperative Pain Therapeutics market has become an essential sector within the healthcare industry, particularly in the wake of increasing surgical procedures and the subsequent need for effective pain management solutions. This market encompasses a wide range of therapeutics designed to alleviate pain following surgical interventions, ensuring patient comfort and satisfaction during recovery. With a focus on improving patient outcomes, the postoperative pain therapeutics market has seen significant advancements, driven…
Postoperative Pain Therapeutics Market Analysis and Forecast (2024-2032)
The introduction serves as the foundational section of our analysis. It aims to provide a comprehensive overview of the Postoperative Pain Therapeutics Market, emphasizing its significance and the purpose of the analysis.
The Postoperative Pain Therapeutics Market plays a pivotal role in the healthcare industry. It addresses the critical need for effective pain management following surgical procedures, contributing to patient comfort and recovery. This market has witnessed substantial growth due to…
Postoperative Nausea and Vomiting Management Market Rising focus on patient comf …
Global Postoperative Nausea and Vomiting Management Market Overview:
The Postoperative Nausea and Vomiting Management market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others.
In recent years, the Postoperative Nausea and Vomiting Management market has experienced significant growth, driven by factors such as increasing consumer demand,…
Prevention and management of postoperative endophthalmitis
The decisive criterion of postoperative endophthalmitis after cataract operations or intravitreal injections is the contamination of the operating area and the instruments / implants with pathogens during the surgical procedure. In traditional operating theaters, the "sterility" is very limited and only given directly under the supply air ceiling. However, the surgical field is almost completely shielded from the ultra-clean air by the surgical microscope and the surgeon's head, so that…
Postoperative Pain Therapeutics Market Projections 2019 – 2027
Transparency Market Research (TMR) has published a new report, titled, ‘Postoperative Pain Therapeutics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027′. According to the postoperative pain therapeutics market report, the global postoperative pain therapeutics market was valued at US$ 11,459.3 Mn in 2018, and is projected to expand at a CAGR of nearly 4.5% from 2019 to 2027. High incidence and severity of postoperative pain, introduction…
